Marinova is an Australian biotechnology company specializing in the development and production of high purity seaweed extracts, particularly fucoidan compounds, which are bioactive polysaccharides derived from select species of brown seaweed. The company serves a diverse range of clients including world-renowned research institutions, pharmaceutical companies, and cosmetic manufacturers. Operating in the global biotechnology market, Marinova's business model revolves around the research, development, and commercialization of its proprietary seaweed extracts. Revenue is generated through the sale of these high-value compounds, which are used in various applications such as medical devices, pharmaceuticals, and cosmeceuticals. Marinova's commitment to scientific innovation and sustainability has positioned it as a leader in fucoidan science.

Keywords: biotechnology, seaweed extracts, fucoidan, polysaccharides, pharmaceutical, cosmeceutical, medical devices, innovation, sustainability, research.